BVS Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into BVS


Also see:
BVS stock yearly return 2021
BVS stock yearly return 2022
BVS stock yearly return 2023
BVS YTD return
Compare BVS average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 02/12/2021
End date: 06/14/2024
Start price/share: $17.22
End price/share: $6.38
Dividends collected/share: $0.00
Total return: -62.95%
BVS Average Annual Return: -25.75%
Starting investment: $10,000.00
Ending investment: $3,705.70
Years: 3.33


BVS average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Bionentus is a global medical device holding company focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and improve the body's natural healing process. Co.'s portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, which is comprised of non-surgical joint pain injection therapies as well as peripheral nerve stimulation products; Surgical Solutions, which is comprised of bone graft substitutes to fuse and grow bones, improve results following spinal and other orthopedic surgeries; and Restorative Therapies, which is comprised of an Ultrasonic bone healing system, among others. The BVS average annual return since 2021 is shown above.

The Average Annual Return on the BVS average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether BVS average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the BVS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree BVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bioventus (BVS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CABA Average Annual Return
CADL Average Annual Return
CAH Average Annual Return
CALC Average Annual Return
CAPR Average Annual Return
CARA Average Annual Return
CARM Average Annual Return
CASI Average Annual Return
CBUS Average Annual Return
CCCC Average Annual Return
More Healthcare companies »

 

BVS Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.